Accrued Expenses and Other Liabilities

3 Months Ended

Mar. 31, 2024

Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities

8. Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following:

	March 31,		December 31,
	2024		2023
Accrued marketing expenses	$	999,997	$	1,013,497
Other expenses		284,613		313,254
Accrued preclinical and clinical trial expenses		371,629		405,792
Compensation and related benefits		492,297		332,641
Accrued manufacturing expenses		11,687		97,877
Advance payments received from customers for manufacturing materials		1,839,149		—
Accrued franchise tax		—		38,800
	$	3,999,372	$	2,201,861